Good news in the fight against breast cancer. A study published in "The Lancet Oncology" finds that when two cancer drugs join forces they significantly reduce tumor size.
Women with "Her-2 Positive" breast cancer were treated with a combination of both drugs. After six weeks, those patients had tumors 22 percent smaller than women taking either drug alone.
Herceptin is already approved for breast cancer. Tykerb has only been used for treatment of advanced cancer. This is the first time they have been tested together.
Copyright 2012 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
If you're hoping to get a jump start on your tan this summer, the Food and Drug Administration has a warning for you.
Want your skin to look great for the summer?
There are a few things you can do between now and then to improve your glow.
A rock song says music can soothe the soul but hospitals are finding it can help premature infants and other sick babies, too.